+987.9%
MRNA vs CSGP
-53.2%
+1,041.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CSGP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +4.0% | +9.1% | +10.2% |
| 7D | +20.6% | +18.3% | +2.3% | +6.7% |
| 30D | +27.1% | +17.8% | +9.4% | +3.9% |
| 3M | +353.4% | +9.3% | +344.1% | +336.6% |
| 6M | +446.3% | -7.9% | +454.2% | +443.0% |
| YTD | +776.2% | -51.5% | +827.7% | +987.4% |
| 1Y | +987.9% | -53.3% | +1,041.2% | +1,285.9% |
| All | +987.9% | -53.2% | +1,041.1% | +1,285.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CSGP.
Daily Out/Under-Performance
Portfolio return minus CSGP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CSGP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CSGP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling